Document is current

Any future updates will be listed below

Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA’s conclusions from the evaluation of 38 suspected cases

Crossref DOI link: https://doi.org/10.1038/s41434-025-00586-x

Published Online: 2025-12-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark